Pharmacokinetic/pharmacodynamic modelling of 2-acetyl-4(5)-tetrahydroxybutyl imidazole-induced peripheral lymphocyte sequestration through increasing lymphoid sphingosine 1-phosphate

By Yu X. Q.   Kramer J.   Moran L.   O’Neill E.   Nouraldeen A.   Oravecz T.   Wilson A. G. E.  

Xenobiotica, Vol. 40, Iss. 5, 2010-05 ,pp. : 350-356

Informa Healthcare

Access to resources Recommend Favorite

Preclinical assessment of novel BRAF inhibitors: integrating pharmacokinetic-pharmacodynamic modelling in the drug discovery process

By Choo Edna F   Alicke Bruno   Boggs Jason   Dinkel Vikki   Gould Stephen   Grina Jonas   West Kristina   Menghrajani Kapil   Ran Yingqing   Rudolph Joachim   Wenglowsky Steve  

Xenobiotica, Vol. 41, Iss. 12, 2011-12 ,pp. : 1076-1087

Informa Healthcare

Access to resources Recommend Favorite

Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic––pharmacodynamic modelling of N-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitor

By Liederer Bianca M.   Berezhkovskiy Leonid M.   Dean Brian J.   Dinkel Vikki   Peng Jing   Merchant Mark   Plise Emile G.   Wong Harvey   Liu Xingrong  

Xenobiotica, Vol. 41, Iss. 4, 2011-04 ,pp. : 327-339

Informa Healthcare

Access to resources Recommend Favorite

Grey-box pharmacokinetic/pharmacodynamic modelling of a euglycaemic clamp study

By Tornøe Christoffer Wenzel   Jacobsen Judith L.   Madsen Henrik  

Journal of Mathematical Biology, Vol. 48, Iss. 6, 2004-06 ,pp. : 591-604

Springer Publishing Company

Access to resources Recommend Favorite

Resveratrol Is a Selective Human Cytochrome P450 1A1 Inhibitor

By Chun Y.J.   Kim M.Y.   Guengerich F.P.  

Biochemical and Biophysical Research Communications, Vol. 262, Iss. 1, 1999-08 ,pp. : 20-24

Elsevier

Access to resources Recommend Favorite